HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

lactobacterin

probiotic Russian drug

Also Known As:

Lactobacterin

Networked: 17 relevant articles (1 outcomes, 1 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Amino Acids, Peptides, and Proteins: 1
- Proteins: 484843
  - Membrane Proteins: 10078
    - Pore Forming Cytotoxic Proteins
      - Bacteriocins: 556
        lactobacterin: 17
  - Bacterial Proteins: 394
    - Bacteriocins: 556
      - lactobacterin: 17

Experts

1.	Il'in, V K: 3 articles (01/2013 - 01/2007)
2.	Kiriukhina, N V: 3 articles (01/2013 - 01/2007)
3.	Starkova, L V: 3 articles (01/2013 - 01/2007)
4.	Usanova, N A: 3 articles (01/2013 - 01/2007)
5.	Istranov, L P: 2 articles (09/2008 - 01/2007)
6.	Kriukov, A I: 2 articles (09/2008 - 01/2007)
7.	Morozova, Iu A: 2 articles (09/2008 - 01/2007)
8.	Volozhin, A I: 2 articles (09/2008 - 01/2007)
9.	Boiarintsev, V V: 1 article (01/2013)
10.	Karaseva, A B: 1 article (01/2013)

Related Diseases

1.	Celiac Disease (Celiac Sprue) 07/01/1991 - "[The efficacy of the use of lactic acid lactobacterin enriched with zinc in the treatment of patients with celiac disease]." 07/01/1991 - "A group of 23 children with celiac disease who received lactic acid lactobacterin without zinc were used as control. " 07/01/1991 - "Zinc sulfate-enriched lactic acid lactobacterin was used in the combined treatment of 23 children with celiac disease, aged from 1 to 10 years. "
2.	Dysbiosis 09/01/1989 - "faecium YDC-48 was found to induce an increase in the level of lactobacterin and a decrease in the number of opportunistic microorganisms in chemotherapeutic and postirradiation dysbacteriosis. " 09/01/1974 - "[Study of the effectiveness of lactobacterin in the treatment of dysentery, colienteritis, and dysbacteriosis of the intestines in children]." 01/01/2013 - "Two preparations were administered to prevent pharyngeal and intestinal dysbiosis: oral dry probiotic based on indigenous intestinal Enterococci and topical collagen-immobilized Lactobacterin based on indigenous intestinal Lactobacilli. " 09/01/2008 - "Two probiotic preparations were administered to prevent pharyngeal dysbiosis: peroral dry lactobacterin and topical collagen-immobilized lactobacterin. " 01/01/2007 - "For prophylactic pharyngeal dysbiosis, we used two probiotic drugs: oral -- "lactobacterin dry" and local --"lactobacterin immobilized on collagen". "
3.	Dysentery 01/01/1974 - "[Use of lactobacterin in the overall treatment of dysentery in children]." 09/01/1974 - "[Study of the effectiveness of lactobacterin in the treatment of dysentery, colienteritis, and dysbacteriosis of the intestines in children]."
4.	Endotoxemia 01/01/1997 - "Administration of bacterial biological preparations (bifidumbacterin forte, lactobacterin) relieves specific endotoxemia, reduces the duration of the disease and has an immunomodulating action."
5.	Wounds and Injuries (Trauma) 01/01/2000 - "The efficiency of eubiotics (bifidumbacterin-forte and lactobacterin, Partner Firm) in local treatment of suppurative wounds was studied in a microbiological experiment and in a clinical setting. "

Related Drugs and Biologics

1.	Lactic Acid (Lactate)
2.	Zinc
3.	bifidobacterin
4.	Collagen
5.	Zinc Sulfate
6.	Mannose (D-Mannose)
7.	Bacterial Vaccines
8.	Anti-Bacterial Agents (Antibiotics)
9.	acilact
10.	bemethyl

Related Therapies and Procedures

1.	Therapeutics